Dr Thomas Colletti
This article aims to review up-to-date scientific data on the recognition and treatment of opioid use disorder in pregnancy. While methadone has historically been the gold standard of treatment, other pharmaceutical options such as buprenorphine and naltrexone, have been shown to be beneficial, and even superior in some circumstances, for both mother and baby. While it is crucial to help the mom obtain sobriety safely, the risk of medication use on neonatal health and the possibility of relapse and recurrent illicit drug use need to be considered. Early recognition of opioid use disorder combined with a multidisciplinary team approach to treatment including medication-assisted therapy and social support is crucial for long-term successful sobriety throughout the antepartum time and beyond.
Ialeggio JE. Opioid Use Disorder in Pregnancy: Managing Two Patients Together. University of Lynchburg DMSc Doctoral Project Assignment Repository. 2022; 4(4).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.